These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 12397090

  • 1. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway.
    Garrido JL, Godoy JA, Alvarez A, Bronfman M, Inestrosa NC.
    FASEB J; 2002 Dec; 16(14):1982-4. PubMed ID: 12397090
    [Abstract] [Full Text] [Related]

  • 2. M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway.
    Farías GG, Godoy JA, Hernández F, Avila J, Fisher A, Inestrosa NC.
    Neurobiol Dis; 2004 Nov; 17(2):337-48. PubMed ID: 15474371
    [Abstract] [Full Text] [Related]

  • 3. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH, Noh MY, Kim SH.
    Brain Res; 2008 Jan 10; 1188():254-62. PubMed ID: 18031715
    [Abstract] [Full Text] [Related]

  • 4. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons.
    Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, Inestrosa NC.
    Exp Cell Res; 2004 Jul 01; 297(1):186-96. PubMed ID: 15194435
    [Abstract] [Full Text] [Related]

  • 5. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ, Burgering BM, van de Wetering M, Clevers HC.
    Int Immunol; 1999 Mar 01; 11(3):317-23. PubMed ID: 10221643
    [Abstract] [Full Text] [Related]

  • 6. The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.
    Farías GG, Godoy JA, Vázquez MC, Adani R, Meshulam H, Avila J, Amitai G, Inestrosa NC.
    Neurobiol Dis; 2005 Feb 01; 18(1):176-83. PubMed ID: 15649708
    [Abstract] [Full Text] [Related]

  • 7. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F, Robinet C, Augé N, Thiers JC, Garcia V, Cambus JP, Salvayre R, Nègre-Salvayre A.
    Cancer Res; 2005 Jan 15; 65(2):526-32. PubMed ID: 15695395
    [Abstract] [Full Text] [Related]

  • 8. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.
    Chen RH, Ding WV, McCormick F.
    J Biol Chem; 2000 Jun 09; 275(23):17894-9. PubMed ID: 10749878
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.
    Cedazo-Mínguez A, Popescu BO, Blanco-Millán JM, Akterin S, Pei JJ, Winblad B, Cowburn RF.
    J Neurochem; 2003 Dec 09; 87(5):1152-64. PubMed ID: 14622095
    [Abstract] [Full Text] [Related]

  • 10. Developmental expression of Wnt signaling factors in mouse brain.
    Coyle-Rink J, Del Valle L, Sweet T, Khalili K, Amini S.
    Cancer Biol Ther; 2002 Dec 09; 1(6):640-5. PubMed ID: 12642687
    [Abstract] [Full Text] [Related]

  • 11. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T, Ninomiya-Tsuji J, Matsumoto K.
    Mol Cell Biol; 2003 Feb 09; 23(4):1379-89. PubMed ID: 12556497
    [Abstract] [Full Text] [Related]

  • 12. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade.
    Golan T, Yaniv A, Bafico A, Liu G, Gazit A.
    J Biol Chem; 2004 Apr 09; 279(15):14879-88. PubMed ID: 14747478
    [Abstract] [Full Text] [Related]

  • 13. [Involvement of Wnt/beta-catenin signaling in tripchlorolide protecting against oligomeric beta-amyloid-(1-42)-induced neuronal apoptosis].
    Wu M, Zhu YG, Pan XD, Lin N, Zhang J, Chen XC.
    Yao Xue Xue Bao; 2010 Jul 09; 45(7):853-9. PubMed ID: 20931782
    [Abstract] [Full Text] [Related]

  • 14. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H, Mao J, Li L, Wu D.
    J Biol Chem; 1999 Oct 22; 274(43):30419-23. PubMed ID: 10521419
    [Abstract] [Full Text] [Related]

  • 15. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
    De Ferrari GV, Chacón MA, Barría MI, Garrido JL, Godoy JA, Olivares G, Reyes AE, Alvarez A, Bronfman M, Inestrosa NC.
    Mol Psychiatry; 2003 Feb 22; 8(2):195-208. PubMed ID: 12610652
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfandiarei M, Si X, Luo Z, Luo H, Rennie PS, McManus BM.
    J Biol Chem; 2005 Apr 01; 280(13):13019-28. PubMed ID: 15668231
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of Puerarin on β-amyloid-induced neurotoxicity in rat hippocampal neurons.
    Lin F, Xie B, Cai F, Wu G.
    Arzneimittelforschung; 2012 Apr 01; 62(4):187-93. PubMed ID: 22278629
    [Abstract] [Full Text] [Related]

  • 18. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C, Weiss JB, Williams LT.
    Proc Natl Acad Sci U S A; 1998 Mar 17; 95(6):3020-3. PubMed ID: 9501208
    [Abstract] [Full Text] [Related]

  • 19. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG, Paulson KE, Yee AS.
    EMBO J; 2001 Aug 15; 20(16):4500-11. PubMed ID: 11500377
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.